Jonathan Clayton


Jonathan Clayton

Clinical Scientist in Biochemistry, Lancashire Teaching Hospitals NHS Foundation Trust

Jonathan’s experience with PCT began in 2010 when he worked with the Intensive Care team at a general hospital in North-West England to develop a protocol based on PCT to reduce antibiotic exposure and assist antibiotic stewardship. On moving to a large teaching hospital in North-West England in 2013, Jonathan’s interest in PCT continued, culminating in becoming a co-applicant and national lab lead for the ADAPT-Sepsis trial. Jonathan is also the author of the Procalcitonin Analyte Monograph alongside the National Laboratory Catalogue (AMALC), published by the UK Association for Laboratory Medicine.